REFERENCES
- Herr HW, Pinsky CM, Whitmore WF et al: Long term effect of intravesical bacillus Calmette-Guérin on flat carcinoma in situ of the bladder. J Urol 1986; 135: 265–267.
- Kelley DR, Haaff EO, Becich M et al: Prognostic value of purified protein deritative skin test and granuloma formation in patients treated with intravesical Bacillus Calmette-Guérin. J Urol 1986; 135: 268–271.
- Khalifa MAAA, Elfving P, Mansson W, Collen S. Bacillus Calmette-Guérin Treatment of 39 patients with superficial transitional cell Carcinoma of the Bladder. Scand J Urol Nephrol 1991; 25: 135–139.
- Lamm DL: Bacillus Calmette-Guérin, immunotherapy for bladder cancer. J Urol 1989; 134: 40–47.
- Morales A, Eidinger D, Bruce AW: Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976; 116: 180–183.
- Rawls WH, Lamm DL, and Egolfson MF: Septic complications in the use of bacillus Calmette-Guérin (BCG) for non invasive transitional cell carcinoma. J Urol 1988; 139: 300A.
- Riddle PR, Chisholm GD, Trott BA, et al: Flat carcinoma in situ of the bladder. Br J Urol 1976; 47: 829–833.
- Sarosdy MF, Lamm DL: Long-term results of intravesical Bacillus Calmette-Guérin therapy for superficial bladder cancer. J Urol 1989; 142: 719–722.
- Smith G, Elton RA, Chisholm GD et al: Superficial bladder cancer: Intravesical chemotherapy and tumor progression to muscle invasion or metastases. Br J Urol 1986; 58: 659–663.
- Utz DC and Farrow GM: Management of carcinoma in situ of the bladder: the case for surgical management. Urol Clin N Am 1980; 7: 533–536.